Clinical trial · Observational
Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors
A Pilot Study of Whole-Neck CT Perfusion With the Toshiba Aquilion ONE ViSION-320 Detector Row CT Scanner for Use in Head &Amp; Neck Tumor Patients
NCT02960308CI-TRIAL-00068756completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This pilot clinical trial studies how well whole-neck computed tomography perfusion scans work in imaging patients with head and neck tumors. Diagnostic imaging procedures, such as whole-neck computed tomography perfusions scans, may provide more information about the blood supply to head and neck tumors which may help doctors plan better treatment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Neoplasm | Head and Neck Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Malignant Head and Neck Neoplasm | Malignant Head and Neck Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Computed Tomography Perfusion Imaging | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Diagnostic (WNCTP scan)
- description
- Patients undergo WNCTP scan over 2-3 minutes during standard of care CT.
- interventionNames
- Radiation: Computed Tomography Perfusion Imaging
Primary outcomes (1)
- measure
- Number and site of each suspicious lymph node assessed by WNCTP
- timeFrame
- Day 1
- description
- Will be compared to traditional neck CTP. Within each patient, the number and sites of each suspicious lymph node will be recorded for the whole-neck imaging area. A 95% confidence interval for the proportion of patients whose status (lymph node negative \[LN-\] versus lymph node positive \[LN+\]) was changed based on the WNCTP image compared to standard of care will be constructed.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Confirmed or suspected head and neck tumor (benign or malignant) * Scheduled for contrast CT (standard of care) * No known allergies to contrast material Exclusion Criteria: * Known allergies to contrast material * Pregnant or nursing
References
Publications (0)
Data not yet available
No reference posted for this study.